Stock ZVSA ZYVERSA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders ZyVersa Therapeutics, Inc.

Equities

ZVSA

US98987D3008

Delayed Nasdaq
Other stock markets
 02:00:01 07/06/2024 am IST 		5-day change 1st Jan Change
4.75 USD -3.06% Intraday chart for ZyVersa Therapeutics, Inc. +16.42% -47.22%
15/05 ZyVersa Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
25/03 ZyVersa Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
ZyVersa Therapeutics, Inc. Announces Board Changes
CI
ZyVersa Therapeutics, Inc. Announces Changes to Board of Directors
CI
Zyversa Therapeutics Announces That Richard J. Glassock Has Joined Zyversa’a Renal Scientific Advisory Board
CI
ZyVersa Therapeutics Reports Inducement Grant to Newly Appointed Chief Medical Officer Under Nasdaq Listing Rule 5635(c)(4)
GL
ZyVersa Therapeutics, Inc. Appoints Dr. Pablo Guzman as Chief Medical Officer and Senior Vice President of Medical Affairs
CI
ZyVersa Therapeutics, Inc. Announces Executive Changes
CI
ZyVersa Therapeutics, Inc. Adds Two Esteemed Leaders to Its Renal Scientific Advisory Board
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ZVSA Stock
  4. News ZyVersa Therapeutics, Inc.
  5. Insiders